Ignite Creation Date:
2024-05-05 @ 11:55 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00174382
Status:
TERMINATED
Last Update Posted:
2015-03-24
First Post:
2005-09-08
Brief Title:
Vaspect Study - An Open-Label Trial Of Donepezil in Vascular and Mixed Dementia
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
An Open-Label Trial Of Donepezil in Vascular and Mixed Dementia
Status:
TERMINATED
Status Verified Date:
2015-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
See Detailed Description
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To document effectiveness safety and tolerability of donepezil in patients with mixed ADVaD and to further document the effectiveness safety and tolerability of donepezil in patients with VaD The effects of donepezil on executive functioning behavior general cognition ADLs and global functioning will be assessed
Detailed Description:
The trial was terminated on October 15 2007 due to difficulties in recruiting the subjects There were no safety or efficacy concerns regarding the study medication in the decision to terminate the trial
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None